This event took place on November 18, 2025. The lecture recording and Q&A are available below.
The state of lung cancer screening and thoracic robotic surgery
PCPs play a crucial role in identifying patients for lung cancer screening and initiating early intervention decisions. Join Areo Saffarzadeh, M.D., thoracic surgeon and director, Robotic Thoracic Surgery at Providence Cancer Institute, in this live event for an in-depth look at the latest in lung cancer screening and treatment approaches, in addition to real-time discussions on ways to improve local screening rates and pathways to treatment for our patients.
Learning Objectives
-
Get the latest on lung cacner screening, locally and nationwide
-
Explore current approaches to diagnosing and treating lung nodules and lung cancer
-
Learn how minimally invasive techniques like robotic and VATS surgery benefit patients
-
Identify ways to boost lung cancer screening rates and streamline care pathways
About the Speaker
 |
Dr. Areo Saffarzadeh Providence Thoracic Surgery – West, PCI Willamette Falls Thoracic Surgery Clinic Dr. Areo Saffarzadeh is an expert thoracic surgeon specializing in minimally invasive surgery in the chest using robotic surgery. He has authored numerous publications and gives presentations around the country on robotic chest surgery and methods to improve accurate diagnosis and outcomes using new technologies. |
Event Recap and Q&A
Virtual Oncology Lecture: The state of lung cancer screening and thoracic robotic surgery
Oncology Lecture Series
Providence Cancer Institute’s virtual oncology lecture series provides busy clinicians with critical updates and clinical pearls from experts they can trust. To find out more about our online clinical learnings or how we collaborate with and support referring clinicians, visit our website.
When it's cancer, choose Providence.
To keep up with the research breakthroughs that are reshaping cancer care, subscribe to our Finish Cancer Through Research newsletter.
Related news
A precision oncology revolution is underway at Providence
Introducing Prevention4Me: A new era in breast cancer risk assessment and early detection
Transforming outcomes in AML and breast cancer: Three open trials at Providence
